316 related articles for article (PubMed ID: 14613958)
21. [Phenotypical curing of Streptococcus pneumoniae treated with amidase induced by the Dp-1 bacteriophage].
García P; García E; Ronda C; López R
Microbiologia; 1985 Sep; 1(1-2):35-41. PubMed ID: 2908322
[TBL] [Abstract][Full Text] [Related]
22. ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain.
Yang H; Gong Y; Zhang H; Etobayeva I; Miernikiewicz P; Luo D; Li X; Zhang X; Dąbrowska K; Nelson DC; He J; Wei H
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30642930
[No Abstract] [Full Text] [Related]
23. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM
Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
[TBL] [Abstract][Full Text] [Related]
24. Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model.
Reed JM; O'Callaghan RJ; Girgis DO; McCormick CC; Caballero AR; Marquart ME
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):604-8. PubMed ID: 15671288
[TBL] [Abstract][Full Text] [Related]
25. A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance.
Resch G; Moreillon P; Fischetti VA
Int J Antimicrob Agents; 2011 Dec; 38(6):516-21. PubMed ID: 21982146
[TBL] [Abstract][Full Text] [Related]
26. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
Hegde SS; Difuntorum S; Skinner R; Trumbull J; Krause KM
J Antimicrob Chemother; 2009 Apr; 63(4):763-6. PubMed ID: 19155225
[TBL] [Abstract][Full Text] [Related]
28. Structural and thermodynamic characterization of Pal, a phage natural chimeric lysin active against pneumococci.
Varea J; Monterroso B; Sáiz JL; López-Zumel C; García JL; Laynez J; García P; Menéndez M
J Biol Chem; 2004 Oct; 279(42):43697-707. PubMed ID: 15247237
[TBL] [Abstract][Full Text] [Related]
29. Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages.
García E; García JL; García P; Arrarás A; Sánchez-Puelles JM; López R
Proc Natl Acad Sci U S A; 1988 Feb; 85(3):914-8. PubMed ID: 3422470
[TBL] [Abstract][Full Text] [Related]
30. Improving the lethal effect of cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module.
Díez-Martínez R; de Paz HD; Bustamante N; García E; Menéndez M; García P
Antimicrob Agents Chemother; 2013 Nov; 57(11):5355-65. PubMed ID: 23959317
[TBL] [Abstract][Full Text] [Related]
31. PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related Species.
Blázquez B; Fresco-Taboada A; Iglesias-Bexiga M; Menéndez M; García P
Front Microbiol; 2016; 7():1156. PubMed ID: 27516758
[TBL] [Abstract][Full Text] [Related]
32. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
33. A real-time polymerase chain reaction for the detection of Streptococcus pneumoniae in blood using a mouse model: a potential new "gold standard".
Rouphael NG; Atwell-Melnick N; Longo D; Whaley M; Carlone GM; Sampson JS; Ades EW
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):23-5. PubMed ID: 18621498
[TBL] [Abstract][Full Text] [Related]
34. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B
Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
[TBL] [Abstract][Full Text] [Related]
36. A phage-associated murein hydrolase in Streptococcus pneumoniae infected with bacteriophage Dp-1.
Garcia P; Garcia E; Ronda C; Lopez R; Tomasz A
J Gen Microbiol; 1983 Feb; 129(2):489-97. PubMed ID: 6132961
[TBL] [Abstract][Full Text] [Related]
37. Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia.
Wang E; Bergeron Y; Bergeron MG
J Antimicrob Chemother; 2005 May; 55(5):721-6. PubMed ID: 15772139
[TBL] [Abstract][Full Text] [Related]
38. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.
Gu J; Xu W; Lei L; Huang J; Feng X; Sun C; Du C; Zuo J; Li Y; Du T; Li L; Han W
J Clin Microbiol; 2011 Jan; 49(1):111-7. PubMed ID: 21048011
[TBL] [Abstract][Full Text] [Related]
39. Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.
Gross M; Clements J; Beckett RP; Thomas W; Taylor S; Lofland D; Ramanathan-Girish S; Garcia M; Difuntorum S; Hoch U; Chen H; Johnson KW
J Antimicrob Chemother; 2004 Mar; 53(3):487-93. PubMed ID: 14963065
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
